About Us Services Careers FAQ Contact Us 0
Home Pharmaceuticals Companion Diagnostics Market Size to reach 15.87 Billion by 2032

Companion Diagnostics Market

Companion Diagnostics Market Size, Share & Trends Analysis Report By Technology (Polymerase Chain Reaction (PCR) , Next-generation Sequencing (NGS), Immunohistochemistry, In Situ Hybridization, Others), By Indication (Oncology, Autoimmune Diseases, Cardiovascular Diseases, Central Nervous System Disorders, Virology Diseases, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031

Report Code: SRPH946DR
Study Period 2019-2031 CAGR 12.8%
Historical Period 2019-2021 Forecast Period 2023-2031
Base Year 2022 Base Year Market Size USD 4.61 Billion
Forecast Year 2031 Forecast Year Market Size USD 13.64 Billion
Largest Market North America Fastest Growing Market Asia-Pacific
Show More
Buy Now
File Formats
The sample report only takes 30 secs to download, no need to wait longer.

Market Segmentation

  1. Companion Diagnostics Market, By Technology (2022-2032)
    1. Polymerase Chain Reaction (PCR) 
    2. Next-generation Sequencing (NGS)
    3. Immunohistochemistry
    4. In Situ Hybridization
    5. Others
  2. Companion Diagnostics Market, By Indication (2022-2032)
    1. Oncology
    2. Autoimmune Diseases
    3. Cardiovascular Diseases
    4. Central Nervous System Disorders
    5. Virology Diseases
    6. Others
    1. North America
      1. North America Companion Diagnostics Market, By Technology
        1. Polymerase Chain Reaction (PCR) 
          1. Next-generation Sequencing (NGS)
            1. Immunohistochemistry
              1. In Situ Hybridization
                1. Others
                2. North America Companion Diagnostics Market, By Indication
                  1. Oncology
                    1. Autoimmune Diseases
                      1. Cardiovascular Diseases
                        1. Central Nervous System Disorders
                          1. Virology Diseases
                            1. Others
                            2. U.S.
                              1. U.S. Companion Diagnostics Market, By Technology
                                1. Polymerase Chain Reaction (PCR) 
                                  1. Next-generation Sequencing (NGS)
                                    1. Immunohistochemistry
                                      1. In Situ Hybridization
                                        1. Others
                                        2. U.S. Companion Diagnostics Market, By Indication
                                          1. Oncology
                                            1. Autoimmune Diseases
                                              1. Cardiovascular Diseases
                                                1. Central Nervous System Disorders
                                                  1. Virology Diseases
                                                    1. Others
                                                  2. Canada
                                                2. Europe
                                                  1. Europe Companion Diagnostics Market, By Technology
                                                    1. Polymerase Chain Reaction (PCR) 
                                                      1. Next-generation Sequencing (NGS)
                                                        1. Immunohistochemistry
                                                          1. In Situ Hybridization
                                                            1. Others
                                                            2. Europe Companion Diagnostics Market, By Indication
                                                              1. Oncology
                                                                1. Autoimmune Diseases
                                                                  1. Cardiovascular Diseases
                                                                    1. Central Nervous System Disorders
                                                                      1. Virology Diseases
                                                                        1. Others
                                                                        2. U.K.
                                                                          1. U.K. Companion Diagnostics Market, By Technology
                                                                            1. Polymerase Chain Reaction (PCR) 
                                                                              1. Next-generation Sequencing (NGS)
                                                                                1. Immunohistochemistry
                                                                                  1. In Situ Hybridization
                                                                                    1. Others
                                                                                    2. U.K. Companion Diagnostics Market, By Indication
                                                                                      1. Oncology
                                                                                        1. Autoimmune Diseases
                                                                                          1. Cardiovascular Diseases
                                                                                            1. Central Nervous System Disorders
                                                                                              1. Virology Diseases
                                                                                                1. Others
                                                                                              2. Germany
                                                                                              3. France
                                                                                              4. Spain
                                                                                              5. Italy
                                                                                              6. Russia
                                                                                              7. Nordic
                                                                                              8. Benelux
                                                                                              9. Rest of Europe
                                                                                            2. APAC
                                                                                              1. APAC Companion Diagnostics Market, By Technology
                                                                                                1. Polymerase Chain Reaction (PCR) 
                                                                                                  1. Next-generation Sequencing (NGS)
                                                                                                    1. Immunohistochemistry
                                                                                                      1. In Situ Hybridization
                                                                                                        1. Others
                                                                                                        2. APAC Companion Diagnostics Market, By Indication
                                                                                                          1. Oncology
                                                                                                            1. Autoimmune Diseases
                                                                                                              1. Cardiovascular Diseases
                                                                                                                1. Central Nervous System Disorders
                                                                                                                  1. Virology Diseases
                                                                                                                    1. Others
                                                                                                                    2. China
                                                                                                                      1. China Companion Diagnostics Market, By Technology
                                                                                                                        1. Polymerase Chain Reaction (PCR) 
                                                                                                                          1. Next-generation Sequencing (NGS)
                                                                                                                            1. Immunohistochemistry
                                                                                                                              1. In Situ Hybridization
                                                                                                                                1. Others
                                                                                                                                2. China Companion Diagnostics Market, By Indication
                                                                                                                                  1. Oncology
                                                                                                                                    1. Autoimmune Diseases
                                                                                                                                      1. Cardiovascular Diseases
                                                                                                                                        1. Central Nervous System Disorders
                                                                                                                                          1. Virology Diseases
                                                                                                                                            1. Others
                                                                                                                                          2. Korea
                                                                                                                                          3. Japan
                                                                                                                                          4. India
                                                                                                                                          5. Australia
                                                                                                                                          6. Singapore
                                                                                                                                          7. Taiwan
                                                                                                                                          8. South East Asia
                                                                                                                                          9. Rest of Asia-Pacific
                                                                                                                                        2. Middle East and Africa
                                                                                                                                          1. Middle East and Africa Companion Diagnostics Market, By Technology
                                                                                                                                            1. Polymerase Chain Reaction (PCR) 
                                                                                                                                              1. Next-generation Sequencing (NGS)
                                                                                                                                                1. Immunohistochemistry
                                                                                                                                                  1. In Situ Hybridization
                                                                                                                                                    1. Others
                                                                                                                                                    2. Middle East and Africa Companion Diagnostics Market, By Indication
                                                                                                                                                      1. Oncology
                                                                                                                                                        1. Autoimmune Diseases
                                                                                                                                                          1. Cardiovascular Diseases
                                                                                                                                                            1. Central Nervous System Disorders
                                                                                                                                                              1. Virology Diseases
                                                                                                                                                                1. Others
                                                                                                                                                                2. UAE
                                                                                                                                                                  1. UAE Companion Diagnostics Market, By Technology
                                                                                                                                                                    1. Polymerase Chain Reaction (PCR) 
                                                                                                                                                                      1. Next-generation Sequencing (NGS)
                                                                                                                                                                        1. Immunohistochemistry
                                                                                                                                                                          1. In Situ Hybridization
                                                                                                                                                                            1. Others
                                                                                                                                                                            2. UAE Companion Diagnostics Market, By Indication
                                                                                                                                                                              1. Oncology
                                                                                                                                                                                1. Autoimmune Diseases
                                                                                                                                                                                  1. Cardiovascular Diseases
                                                                                                                                                                                    1. Central Nervous System Disorders
                                                                                                                                                                                      1. Virology Diseases
                                                                                                                                                                                        1. Others
                                                                                                                                                                                      2. Turkey
                                                                                                                                                                                      3. Saudi Arabia
                                                                                                                                                                                      4. South Africa
                                                                                                                                                                                      5. Egypt
                                                                                                                                                                                      6. Nigeria
                                                                                                                                                                                      7. Rest of MEA
                                                                                                                                                                                    2. LATAM
                                                                                                                                                                                      1. LATAM Companion Diagnostics Market, By Technology
                                                                                                                                                                                        1. Polymerase Chain Reaction (PCR) 
                                                                                                                                                                                          1. Next-generation Sequencing (NGS)
                                                                                                                                                                                            1. Immunohistochemistry
                                                                                                                                                                                              1. In Situ Hybridization
                                                                                                                                                                                                1. Others
                                                                                                                                                                                                2. LATAM Companion Diagnostics Market, By Indication
                                                                                                                                                                                                  1. Oncology
                                                                                                                                                                                                    1. Autoimmune Diseases
                                                                                                                                                                                                      1. Cardiovascular Diseases
                                                                                                                                                                                                        1. Central Nervous System Disorders
                                                                                                                                                                                                          1. Virology Diseases
                                                                                                                                                                                                            1. Others
                                                                                                                                                                                                            2. Brazil
                                                                                                                                                                                                              1. Brazil Companion Diagnostics Market, By Technology
                                                                                                                                                                                                                1. Polymerase Chain Reaction (PCR) 
                                                                                                                                                                                                                  1. Next-generation Sequencing (NGS)
                                                                                                                                                                                                                    1. Immunohistochemistry
                                                                                                                                                                                                                      1. In Situ Hybridization
                                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                                        2. Brazil Companion Diagnostics Market, By Indication
                                                                                                                                                                                                                          1. Oncology
                                                                                                                                                                                                                            1. Autoimmune Diseases
                                                                                                                                                                                                                              1. Cardiovascular Diseases
                                                                                                                                                                                                                                1. Central Nervous System Disorders
                                                                                                                                                                                                                                  1. Virology Diseases
                                                                                                                                                                                                                                    1. Others
                                                                                                                                                                                                                                  2. Mexico
                                                                                                                                                                                                                                  3. Argentina
                                                                                                                                                                                                                                  4. Chile
                                                                                                                                                                                                                                  5. Colombia
                                                                                                                                                                                                                                  6. Rest of LATAM

                                                                                                                                                                                                                              Related Reports

                                                                                                                                                                                                                              Global Report
                                                                                                                                                                                                                              The global clinical diagnostics market size was valued at USD 67.29 billion in 2021. It is expected to reach USD 109.70 billion by 2030, growing at a CAGR of 6.3% during the forecast period (2022–2030). Clinical diagnostic tests are increasing
                                                                                                                                                                                                                              Buy Now
                                                                                                                                                                                                                              Global Report
                                                                                                                                                                                                                              The global COVID-19 diagnostics market was valued at USD 84500 million in 2020 and is expected to grow at 3.2% CAGR during the forecast period. In 2019, a new coronavirus strain was identified to have caused a disease outbreak originating in Wuhan,
                                                                                                                                                                                                                              Buy Now
                                                                                                                                                                                                                              Global Report
                                                                                                                                                                                                                              The global sepsis diagnostics market size was valued at USD 685 million in 2022. It is expected to reach USD 1,427.44 million by 2031 at a CAGR of 8.5% during the projected period (2023–2031). Factors such as increasing prevalence of
                                                                                                                                                                                                                              Buy Now
                                                                                                                                                                                                                              Global Report
                                                                                                                                                                                                                              The global TB diagnostics market size was valued at USD 1,337.30 million in 2021 and is expected to reach a valuation of USD 2,148 million by 2030 growing at a CAGR of 5.56% during the forecast period (2022–2030). Tuberculosis (TB) is a contag
                                                                                                                                                                                                                              Buy Now
                                                                                                                                                                                                                              Global Report
                                                                                                                                                                                                                              The global transplant diagnostics market size was valued at USD 3,550 million in 2019 and is expected to grow with a CAGR of 7.4% during the forecast period, 2020–2029. Organ transplantation is a surgical procedure of removing healthy org
                                                                                                                                                                                                                              Buy Now

                                                                                                                                                                                                                              Purchase Benefits

                                                                                                                                                                                                                              • Eligible for a free updated report next year
                                                                                                                                                                                                                              • Completely customizable scope
                                                                                                                                                                                                                              • 30% discount on your next purchase
                                                                                                                                                                                                                              • Dedicated account manager
                                                                                                                                                                                                                              • Query resolution within 24 hours
                                                                                                                                                                                                                              • Permission to print the report

                                                                                                                                                                                                                              We are featured on :

                                                                                                                                                                                                                              www.straitsresearch.com
                                                                                                                                                                                                                              © Copyright . All rights Reserved.